M
Maud Lemoine
Researcher at Imperial College London
Publications - 171
Citations - 4592
Maud Lemoine is an academic researcher from Imperial College London. The author has contributed to research in topics: Hepatitis B & Hepatitis B virus. The author has an hindex of 29, co-authored 138 publications receiving 3539 citations. Previous affiliations of Maud Lemoine include Pierre-and-Marie-Curie University & Royal College of Physicians.
Papers
More filters
Journal ArticleDOI
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke,Isabelle Andrieux-Meyer,Tanya L. Applegate,Rifat Atun,Jessica R Burry,Hugo Cheinquer,G.M. Dusheiko,Jordan J. Feld,Charles Gore,Max Griswold,Saeed Hamid,Margaret Hellard,Jinlin Hou,J. Howell,Jidong Jia,Natalia Kravchenko,Jeffrey V. Lazarus,Maud Lemoine,Olufunmilayo A. Lesi,Liudmyla Maistat,Brian J. McMahon,Homie Razavi,Teri Roberts,Bryony Simmons,Mark W. Sonderup,C Wendy Spearman,Bridie E Taylor,David L. Thomas,Imam Waked,John W. Ward,Stefan Wiktor,Ayman Abdo,Rakesh Aggarwal,Alessio Aghemo,Bandar Al-Judaibi,Mamun Al Mahtab,Arshad Altaf,Zyaad Ameen,Tarik Asselah,Oidov Baatarkkhuu,Ella Barber,Eleanor Barnes,Pascale Boulet,Louise Burrows,Maia Butsashvili,Erica Chan,Chelsea Chow,Ben Cowie,Chris Cunningham,Alexandre de Araujo,Graciela Diap,G.J. Dore,Joseph Doyle,Manal Elsayed,Emmanuel Fajardo,Edward Gane,Aneley Getahun,David J. Goldberg,Tiffany Got,Matthew Hickman,Andrew F. Hill,Sharon J. Hutchinson,Christopher R. Jones,Saleem Kamili,Amreen Khan,Alice Lee,Tin Yan Lee,Jioiji Malani,Tammy Meyers Morris,Shevanthi Nayagam,Richard Njouom,Ponsiano Ocama,Alisa Pedrana,Rosanna W. Peeling,Amulya Reddy,Jilian A. Sacks,Shiv Kumar Sarin,Yusuke Shimakawa,Marcela Silva,Pavlo Skala,Simon D. Taylor-Robinson,Alexander J. Thompson,Mark Thursz,Alfred Tonganibeia,Jack Wallace,James Ward,Fernando Herz Wolff,Peter Vickerman,Johnny Yau +88 more
TL;DR: Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020.
Journal ArticleDOI
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
Fadila Benhamed,Pierre-Damien Denechaud,Maud Lemoine,Céline Robichon,Marthe Moldes,Justine Bertrand-Michel,Vlad Ratziu,Lawrence Serfaty,Chantal Housset,Jacqueline Capeau,Jean Girard,Hervé Guillou,Catherine Postic +12 more
TL;DR: It is demonstrated that increased ChREBP can dissociate hepatic steatosis from insulin resistance, with beneficial effects on both glucose and lipid metabolism.
Journal ArticleDOI
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa
Maud Lemoine,Maud Lemoine,Yusuke Shimakawa,Yusuke Shimakawa,Shevanthi Nayagam,Mustapha Khalil,Penda Suso,Jo Lloyd,Robert D. Goldin,Harr-Freeya Njai,Gibril Ndow,Makie Taal,Graham S Cooke,Umberto D'Alessandro,Muriel Vray,Papa Saliou Mbaye,Ramou Njie,Vincent Mallet,Mark Thursz +18 more
TL;DR: The GPR is a more accurate routine laboratory marker than APRI and Fib-4 to stage liver fibrosis in patients with CHB in West Africa and represents a simple and inexpensive alternative to liver biopsy and Fibroscan in sub-Saharan Africa.
Journal ArticleDOI
Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis
Maud Lemoine,Sandrine Katsahian,Marianne Ziol,Pierre Nahon,Nathalie Ganne-Carrié,F. Kazemi,Véronique Grando-Lemaire,Jean-Claude Trinchet,Michel Beaugrand +8 more
TL;DR: This data indicates that liver stiffness measurement is a non‐invasive method for liver fibrosis assessment and Hepatic venous pressure gradient (HVPG) is the gold standard for assessing the presence and the severity of portal hypertension (PHT).
Journal ArticleDOI
Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.
TL;DR: NAFLD is frequently observed in HIV-monoinfected patients, and NASH is a common cause of unexplained abnormal liver function in patients selected for liver biopsy.